In the context of HD patients, the repeat track of TCERG1 was initially found to have a slight contribution to disease age of onset (40), while more recent genome-wide studies by GEM-HD found that TCERG1 was one of the most significant age-of-onset hits (44). This evidence concerns the gene TCERG1 and Huntington disease.